BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11750969)

  • 1. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of low molecular weight heparin. Gynecological ward retrospective analysis.
    Cyrkowicz A
    Eur J Obstet Gynecol Reprod Biol; 2002 Jan; 100(2):223-6. PubMed ID: 11750969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of deep vein thrombosis (DVT) with the low molecular weight heparin (LMWH) and epidural/spinal anesthesia. The efficacy viewpoint].
    Cyrkowicz A; Fiala J; Kacalski J; Jackowski P; Bielaszka K; Smida A
    Ginekol Pol; 1998 Nov; 69(11):795-9. PubMed ID: 10337069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients.
    Lee TH; Alonzo BJ; Differding J; Underwood SJ; Hamilton G; Kremenevskiy I; McNamara S; Schreiber MA
    J Trauma Acute Care Surg; 2013 Feb; 74(2):476-81. PubMed ID: 23354241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
    Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
    Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
    Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Prophylaxis Protocols for Venous Thromboembolism in Neurosurgery: Results from a Prospective Comparative Study on Low-Molecular-Weight Heparin, Elastic Stockings, and Intermittent Pneumatic Compression Devices.
    Chibbaro S; Cebula H; Todeschi J; Fricia M; Vigouroux D; Abid H; Kourbanhoussen H; Pop R; Nannavecchia B; Gubian A; Prisco L; Ligarotti GKI; Proust F; Ganau M
    World Neurosurg; 2018 Jan; 109():e510-e516. PubMed ID: 29033376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enoxaparin for the prevention of post surgical pulmonary embolism].
    Xia XY; Tan YL; Sun YW; Yan GD; Rong YX; Ren QH; Liu JY; Xu XZ; Shan GP; Jin L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Nov; 23(11):661-4. PubMed ID: 22093311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of weight-adapted nadroparin calcium vs. heparin sodium in prevention of clinically evident thromboembolic complications in 1,190 general surgical patients.
    Egger B; Schmid SW; Naef M; Wildi S; Büchler MW
    Dig Surg; 2000; 17(6):602-609. PubMed ID: 11155006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage.
    Orken DN; Kenangil G; Ozkurt H; Guner C; Gundogdu L; Basak M; Forta H
    Neurologist; 2009 Nov; 15(6):329-31. PubMed ID: 19901711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
    Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
    Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
    Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I
    Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution in the pharmacological treatment of venous thrombosis according to evidence-based medicine].
    Manganaro A; Giannino D; Lembo D; Bruni F; Consolo F
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):41-51. PubMed ID: 11253339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
    Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
    Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice.
    Zidane M; van Hulsteijn LH; Brenninkmeijer BJ; Huisman MV
    Haematologica; 2006 Aug; 91(8):1052-8. PubMed ID: 16885045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of low molecular weight heparin and low dose unfractionated heparin prophylaxis in subacute myelopathy.
    Spivack SB; Aisen ML
    J Spinal Cord Med; 1997 Oct; 20(4):402-5. PubMed ID: 9360220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep vein thrombosis and pulmonary embolism in the perioperative patient.
    Muntz JE
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1045-52. PubMed ID: 11484304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.